Temozolomide Plus Bevacizumab in Supratentorial Glioblastoma in 70 Years and Older Patients With an Impaired Functional Status

NCT02898012 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma Multiforme
Primary Brain Tumor

Interventions

DRUG: Temozolomide
DRUG: Bevacizumab

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]